BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ansari, E. A
Right arrow Articles by Littlewood, J. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ansari, E. A
Right arrow Articles by Littlewood, J. M
Br J Ophthalmol 1999;83:688-691 ( June )

Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements

Ejaz A Ansaria, Kamal Sahnia, Christine Etheringtonb, Alison Mortonb, Steven P Conwayb, Eduardo Moyab, James M Littlewoodb

a Department of Ophthalmology, St James's and Seacroft University Hospitals, Leeds LS14 6UH, b Regional Paediatric and Adult Cystic Fibrosis Unit at St James's and Seacroft University Hospitals, Leeds LS14 6UH

Correspondence to: Mr E A Ansari, Department of Ophthalmology, Ward A4, Cardiff Eye Unit, University Hospital of Wales, Cardiff CF4 4XW.

Accepted for publication 10 December 1998

BACKGROUND/AIMS---Patients with cystic fibrosis (CF) may have low plasma vitamin A levels from malabsorption, zinc deficiency, liver disease, or poor compliance with prescribed supplements. In view of the increasing number of adults with CF, many of whom drive cars, it is important to assess vitamin A status. In our centre an attempt has been made to achieve normal levels of fat soluble vitamins by annual estimation of plasma levels and appropriate oral supplementation. This study aimed to determine if this approach prevents vitamin A deficiency and the consequent problems with dark adaptation.
METHODS---The study was conducted at the regional adult and paediatric cystic fibrosis unit and the patients were recruited from there. Dark adaptation studies were conducted at the department of ophthalmology, St James's University Hospital. All patients are regularly seen in the outpatient department by a CF specialist dietitian and have a comprehensive annual dietary assessment. 28 patients had the following investigations: serum retinol, plasma zinc, serum retinol binding protein, liver function tests, dark adaptation, contrast sensitivity, and anterior ocular surface status. 25 age and sex matched controls without CF or ocular pathology were also recruited for the dark adaptation study.
RESULTS---None of the patients had vitamin A deficiency, the median value of serum retinol being 48 µg/dl, range 31-80 µg/dl (normal range 30-80 µg/dl). Dark adaptation was normal in all cases compared with the control group where the mean value was 3.4 log units of threshold luminance (95% confidence interval 2.4-4.0). None of the test group had a value of threshold luminance 2 SD above the mean value for the control group. Eight patients had reduced contrast sensitivity. The median value for serum zinc was 14.2 µmol/ l, range 13-81 µmol/l (normal range 8-23 µmol/l) and the median value for retinol binding protein was 36 mg/l, range 13-81 mg/l (normal range 35-58 mg/l). There was no correlation between dark adaptation and serum retinol, zinc, or retinol binding protein. Two patients had clinical evidence of dry eye.
CONCLUSION---Regular estimates of plasma vitamin A together with appropriate supplementation and expert dietetic review can maintain normal dark adaptation in patients with cystic fibrosis. The occurrence of reduced contrast sensitivity function is well documented but remains an unexplained phenomenon and deserves further study.


© 1999 by British Journal of Ophthalmology



This article has been cited by other articles:


Home page
IOVSHome page
M. H. Levin and A. S. Verkman
CFTR-Regulated Chloride Transport at the Ocular Surface in Living Mice Measured by Potential Differences
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1428 - 1434.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Schupp, E. Olano-Martin, C. Gerth, B. M Morrissey, C. E Cross, and J. S Werner
Lutein, zeaxanthin, macular pigment, and visual function in adult cystic fibrosis patients
Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1045 - 1052.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 by the BMJ Publishing Group Ltd.